Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Introduction
00:00 • 2min
Breakpoints: Dr. Jason Pogue and Dr. Mike Satlin
01:48 • 2min
Breakpoints for Enterobacteralis and Pseudomonas
03:34 • 4min
Aminoglycosides as Monotherapy for Urinary Tract Infections
07:18 • 4min
The History of Breakpoints in the M100
10:49 • 2min
The Importance of Understanding the Amine Glakisside Breakpoints
12:53 • 4min
The Importance of Stasis Break Points in PKPD
17:12 • 6min
Setting Break Points at Stasis Endpoints
22:46 • 2min
The Problem With Break Points in Microbiology
25:00 • 2min
The Safety of Flipping the Distribution of Drugs
26:45 • 2min
Pseudomonas and Aminoglycosides: A Comparison
28:24 • 2min
The New Truth About Gentomycin and Pseudomonas
30:00 • 2min
Toba and Pseutomonas: A Comparison
31:48 • 3min
The U S Cast: A Side Break Point for Pseudomonas
34:29 • 2min
The FDA's Not Had a Crack at Poly Mixins
36:00 • 2min
Amina Glycosides: Are They Real Yet?
38:01 • 3min